KAVAPRO

What this means for you

Not registered yet, but its 11 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98896720

Mark type

Stylized text

Filed

11 Dec 2024

Published for opposition

08 Apr 2025

Goods and services

• Class 005 — Pharmaceuticals: Dietary supplements; nutritional supplements; dietary supplements and nutritional supplements containing kava; pharmaceutical preparation, namely kava being a dietary ingredient manufactured by a proprietary process that results in kava being absorbed in the intestinal tract in a time-dependent manner; pharmaceutical feature in the nature of a sustained-release delivery ingredient in the nature of dietary supplements and nutritional supplements, made in significant part from kava, sold as an integral component of dietary supplements and nutritional supplements for alleviating anxiousness, improving mood, relieving tension, improving sleep, and supporting cognitive function.

Owner

• Tesseract Medical Research, LLC, Laguna Hills, CA, US
• Tesseract Medical Research, LLC, Laguna Hills, CA, US

Prosecution history

• 30 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 30 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 19 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
• 12 Sept 2025 — USE AMENDMENT FILED
• 19 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 12 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
• 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 08 Apr 2025 — PUBLISHED FOR OPPOSITION
• 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 12 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 04 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 04 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 04 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 04 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED